JP2012509931A5 - - Google Patents

Download PDF

Info

Publication number
JP2012509931A5
JP2012509931A5 JP2011538083A JP2011538083A JP2012509931A5 JP 2012509931 A5 JP2012509931 A5 JP 2012509931A5 JP 2011538083 A JP2011538083 A JP 2011538083A JP 2011538083 A JP2011538083 A JP 2011538083A JP 2012509931 A5 JP2012509931 A5 JP 2012509931A5
Authority
JP
Japan
Prior art keywords
amino
methyl
anhydro
dideoxy
diazabicyclo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011538083A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012509931A (ja
JP5108153B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2009/055232 external-priority patent/WO2010061329A1/en
Publication of JP2012509931A publication Critical patent/JP2012509931A/ja
Publication of JP2012509931A5 publication Critical patent/JP2012509931A5/ja
Application granted granted Critical
Publication of JP5108153B2 publication Critical patent/JP5108153B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011538083A 2008-11-26 2009-11-20 ケモカイン受容体モジュレーターとしての3−アミノシクロペンタンカルボキサミド Active JP5108153B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11805308P 2008-11-26 2008-11-26
US61/118,053 2008-11-26
PCT/IB2009/055232 WO2010061329A1 (en) 2008-11-26 2009-11-20 3-aminocyclopentanecarboxamides as chemokine receptor modulators

Publications (3)

Publication Number Publication Date
JP2012509931A JP2012509931A (ja) 2012-04-26
JP2012509931A5 true JP2012509931A5 (cg-RX-API-DMAC7.html) 2012-08-09
JP5108153B2 JP5108153B2 (ja) 2012-12-26

Family

ID=41693100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011538083A Active JP5108153B2 (ja) 2008-11-26 2009-11-20 ケモカイン受容体モジュレーターとしての3−アミノシクロペンタンカルボキサミド

Country Status (38)

Country Link
US (2) US8293903B2 (cg-RX-API-DMAC7.html)
EP (1) EP2370442B9 (cg-RX-API-DMAC7.html)
JP (1) JP5108153B2 (cg-RX-API-DMAC7.html)
KR (1) KR101374412B1 (cg-RX-API-DMAC7.html)
CN (1) CN102227429B (cg-RX-API-DMAC7.html)
AP (1) AP3113A (cg-RX-API-DMAC7.html)
AU (1) AU2009321221B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0920936A2 (cg-RX-API-DMAC7.html)
CA (1) CA2743030C (cg-RX-API-DMAC7.html)
CL (1) CL2011001223A1 (cg-RX-API-DMAC7.html)
CO (1) CO6361921A2 (cg-RX-API-DMAC7.html)
CR (1) CR20110275A (cg-RX-API-DMAC7.html)
CU (1) CU24022B1 (cg-RX-API-DMAC7.html)
CY (1) CY1114020T1 (cg-RX-API-DMAC7.html)
DK (1) DK2370442T5 (cg-RX-API-DMAC7.html)
DO (1) DOP2011000154A (cg-RX-API-DMAC7.html)
EA (1) EA020470B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP11011081A (cg-RX-API-DMAC7.html)
ES (1) ES2415430T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20146064B (cg-RX-API-DMAC7.html)
HR (1) HRP20130409T2 (cg-RX-API-DMAC7.html)
IL (1) IL212732A (cg-RX-API-DMAC7.html)
MA (1) MA32834B1 (cg-RX-API-DMAC7.html)
ME (1) ME01144B (cg-RX-API-DMAC7.html)
MX (1) MX2011005526A (cg-RX-API-DMAC7.html)
MY (1) MY152557A (cg-RX-API-DMAC7.html)
NI (1) NI201100102A (cg-RX-API-DMAC7.html)
NZ (1) NZ592919A (cg-RX-API-DMAC7.html)
PE (1) PE20110831A1 (cg-RX-API-DMAC7.html)
PL (1) PL2370442T3 (cg-RX-API-DMAC7.html)
PT (1) PT2370442E (cg-RX-API-DMAC7.html)
RS (2) RS52810B9 (cg-RX-API-DMAC7.html)
SI (1) SI2370442T1 (cg-RX-API-DMAC7.html)
SV (1) SV2011003923A (cg-RX-API-DMAC7.html)
TN (1) TN2011000254A1 (cg-RX-API-DMAC7.html)
UA (1) UA99978C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010061329A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201104069B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20130409T2 (hr) * 2008-11-26 2013-11-22 Pfizer Inc. 3-aminociklopentankarboksamidi kao modulatori kemokinskih receptora
KR101303963B1 (ko) * 2011-04-08 2013-09-05 재단법인 경기과학기술진흥원 (1r,2r,3r)-3-아미노사이클로펜탄-1,2-디올을 포함하는 항알러지용 조성물
SG11201608303QA (en) 2014-04-04 2016-11-29 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
JP2016029038A (ja) * 2014-07-17 2016-03-03 参天製薬株式会社 加齢黄斑変性の予防または治療剤
JOP20190040A1 (ar) * 2016-09-14 2019-03-10 Novartis Ag توليفة من ناهضات fxr
TWI830733B (zh) * 2018-05-11 2024-02-01 中國大陸商迪哲(江蘇)醫藥有限公司 環戊烷化合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015973A1 (en) 1993-12-06 1995-06-15 Cytel Corporation Cs-1 peptidomimetics, compositions and methods of using the same
US5510332A (en) 1994-07-07 1996-04-23 Texas Biotechnology Corporation Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor
AU2964295A (en) 1994-07-11 1996-02-09 Athena Neurosciences, Inc. Inhibitors of leukocyte adhesion
US5462208A (en) 1994-08-01 1995-10-31 The Procter & Gamble Company Two-phase dispensing systems utilizing bellows pumps
US5811391A (en) 1994-08-25 1998-09-22 Cytel Corporation Cyclic CS-1 peptidomimetics, compositions and methods of using same
GB9524630D0 (en) 1994-12-24 1996-01-31 Zeneca Ltd Chemical compounds
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
WO1996031206A2 (en) 1995-04-07 1996-10-10 Warner-Lambert Company Flavones and coumarins as agents for the treatment of atherosclerosis
US5704960A (en) 1995-12-20 1998-01-06 Corning, Inc. Method of forming an optical fiber for reduced polarization effects in amplifiers
GB9603741D0 (en) 1996-02-22 1996-04-24 Lin Mei Treatment of water by electrolysis
JP2000516210A (ja) 1996-07-12 2000-12-05 ロイコサイト,インコーポレーテッド ケモカインレセプターアンタゴニストとその使用方法
WO1998042656A1 (en) 1997-03-21 1998-10-01 Cytel Corporation Novel compounds
JP2002501537A (ja) 1997-05-29 2002-01-15 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としてのスルホンアミド類
CA2291778A1 (en) 1997-05-29 1998-12-03 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
ES2257808T3 (es) 1997-05-29 2006-08-01 MERCK & CO., INC. (A NEW JERSEY CORP.) Acidos biarilalcanoicos como inhibidores de adhesion celular.
ATE256699T1 (de) 1997-05-30 2004-01-15 Celltech Therapeutics Ltd Entzündungshemmende tyrosin-derivate
WO1998058902A1 (en) 1997-06-23 1998-12-30 Tanabe Seiyaku Co., Ltd. INHIBITORS OF α4β1MEDIATED CELL ADHESION
US6312689B1 (en) 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
CA2483752C (en) * 2002-04-29 2011-03-29 Merck & Co., Inc. Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
TWI262077B (en) * 2002-04-29 2006-09-21 Merck & Co Inc Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
DK1696919T3 (da) * 2003-12-18 2013-12-09 Incyte Corp 3-cycloalkylaminopyrrolidin-derivater som modulatorer af chemokinreceptorer
JP4845873B2 (ja) * 2004-03-03 2011-12-28 ケモセントリックス インコーポレーティッド 二環式および架橋した窒素複素環
AU2005237500A1 (en) 2004-04-28 2005-11-10 Merck Sharp & Dohme Corp. 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity
JP4116671B2 (ja) * 2004-06-28 2008-07-09 インサイト コーポレイション ケモカイン受容体の調節剤としての3−アミノシクロペンタンカルボキサミド
MXPA06014672A (es) * 2004-06-28 2007-03-26 Incyte Corp 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas.
CN1976702A (zh) * 2004-06-28 2007-06-06 因赛特公司 作为趋化因子受体调节剂的3-氨基环戊烷甲酰胺类
MEP1008A (xx) * 2005-12-21 2010-02-10 Incyte Corp 3-aminociklopentankarboksamidi kao modulatori receptora hemokina
HRP20130409T2 (hr) * 2008-11-26 2013-11-22 Pfizer Inc. 3-aminociklopentankarboksamidi kao modulatori kemokinskih receptora

Similar Documents

Publication Publication Date Title
JP2018534326A5 (cg-RX-API-DMAC7.html)
US11197867B2 (en) Aminopyrimidinyl compounds
JP2012509931A5 (cg-RX-API-DMAC7.html)
JP6162144B2 (ja) 4,4−二置換−1,4−ジヒドロピリミジン、及びb型肝炎の処置のための医薬としてのその使用
JP2016523911A5 (cg-RX-API-DMAC7.html)
IL273924B1 (en) Muscarinic acetylcholine M4 receptor antagonists
AU2012299080B2 (en) Pyrimidine PDE10 inhibitors
HRP20160326T1 (hr) Derivati piperidin-4-il azetidina kao inhibitori jak1
JP2013522214A5 (cg-RX-API-DMAC7.html)
HRP20110158T1 (hr) Biaril eterski spojevi ureje
JP2018538307A5 (cg-RX-API-DMAC7.html)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2013545779A5 (cg-RX-API-DMAC7.html)
JP2013533300A (ja) ブルトン型チロシンキナーゼの阻害剤
HRP20180357T1 (hr) Inhibitori bromodomene
HRP20180384T1 (hr) Derivati 2,3-dihidro-benzo[1,4]oksazina i odgovarajući spojevi kao inhibitori kinaze fosfoinozitida-3 (pi3k) za liječenje primjerice reumatoidnog artritisa
WO2014147586A1 (en) 1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as inhibitors of mutant idh
JP2017523215A5 (cg-RX-API-DMAC7.html)
WO2019034973A1 (en) PYRAZOLO [1,5-A] PYRAZIN-4-YL AND RELATED DERIVATIVES
JP2019530708A5 (cg-RX-API-DMAC7.html)
JP2023021277A5 (cg-RX-API-DMAC7.html)
TW201247657A (en) Isoxazolines as therapeutic agents
RU2014118966A (ru) Способ получения изоксазолил-метокси-никотиновых кислот
HRP20130409T2 (hr) 3-aminociklopentankarboksamidi kao modulatori kemokinskih receptora
RU2023122189A (ru) Пиразоламидные производные